SARS-CoV-2 mRNA vaccination induces an immune response in the nasal mucosa, study finds

Roche plans to rein­tro­duce Susvi­mo, its oc­u­lar im­plant pulled al­most two years ago for man­u­fac­tur­ing is­sues, in the com­ing weeks. In late 2022, the com­pa­ny’

As-needed albuterol-budesonide (Airsupra) more effectively improved lung function in moderate-to-severe asthma than as-needed albuterol only, according to research presented at the CHEST annual meeting hosted

Sat­suma Phar­ma­ceu­ti­cals was hand­ed a com­plete re­sponse let­ter for its nasal mi­graine drug af­ter the agency found is­sues with the prod­uct’s chem­istry, man­u­fac­tur­ing and con­trols. No